These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2299645)
1. Some benzyl-substituted imidazoles, triazoles, tetrazoles, pyridinethiones, and structural relatives as multisubstrate inhibitors of dopamine beta-hydroxylase. 4. Structure-activity relationships at the copper binding site. Kruse LI; Kaiser C; DeWolf WE; Finkelstein JA; Frazee JS; Hilbert EL; Ross ST; Flaim KE; Sawyer JL J Med Chem; 1990 Feb; 33(2):781-9. PubMed ID: 2299645 [TBL] [Abstract][Full Text] [Related]
2. Multisubstrate inhibitors of dopamine beta-hydroxylase. 1. Some 1-phenyl and 1-phenyl-bridged derivatives of imidazole-2-thione. Kruse LI; Kaiser C; DeWolf WE; Frazee JS; Garvey E; Hilbert EL; Faulkner WA; Flaim KE; Sawyer JL; Berkowitz BA J Med Chem; 1986 Dec; 29(12):2465-72. PubMed ID: 3783606 [TBL] [Abstract][Full Text] [Related]
3. Inhibitors of dopamine beta-hydroxylase. 3. Some 1-(pyridylmethyl)imidazole-2-thiones. Ross ST; Kruse LI; Ohlstein EH; Erickson RW; Ezekiel M; Flaim KE; Sawyer JL; Berkowitz BA J Med Chem; 1987 Aug; 30(8):1309-13. PubMed ID: 3612682 [TBL] [Abstract][Full Text] [Related]
4. Multisubstrate inhibitors of dopamine beta-hydroxylase. 2. Structure-activity relationships at the phenethylamine binding site. Kruse LI; Kaiser C; DeWolf WE; Frazee JS; Ross ST; Wawro J; Wise M; Flaim KE; Sawyer JL; Erickson RW J Med Chem; 1987 Mar; 30(3):486-94. PubMed ID: 3820219 [TBL] [Abstract][Full Text] [Related]
5. Design and kinetic characterization of multisubstrate inhibitors of dopamine beta-hydroxylase. Kruse LI; DeWolf WE; Chambers PA; Goodhart PJ Biochemistry; 1986 Nov; 25(23):7271-8. PubMed ID: 3801416 [TBL] [Abstract][Full Text] [Related]
6. 1-(substituted-benzyl)imidazole-2(3H)-thione inhibitors of dopamine beta-hydroxylase. Burke BJ; Hopfinger AJ J Med Chem; 1990 Jan; 33(1):274-81. PubMed ID: 2296023 [TBL] [Abstract][Full Text] [Related]
7. 1-(Thienylalkyl)imidazole-2(3H)-thiones as potent competitive inhibitors of dopamine beta-hydroxylase. McCarthy JR; Matthews DP; Broersma RJ; McDermott RD; Kastner PR; Hornsperger JM; Demeter DA; Weintraub HJ; Whitten JP J Med Chem; 1990 Jul; 33(7):1866-73. PubMed ID: 2362264 [TBL] [Abstract][Full Text] [Related]
8. The copper sites of dopamine beta-hydroxylase: an X-ray absorption spectroscopic study. Scott RA; Sullivan RJ; DeWolf WE; Dolle RE; Kruse LI Biochemistry; 1988 Jul; 27(15):5411-7. PubMed ID: 3179263 [TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical importance and synthetic strategies for imidazolidine-2-thione and imidazole-2-thione derivatives. Savjani JK; Gajjar AK Pak J Biol Sci; 2011 Dec; 14(24):1076-89. PubMed ID: 22335047 [TBL] [Abstract][Full Text] [Related]
10. 4-Trifluoromethylimidazoles and 5-(4-pyridyl)-1,2,4-triazoles, new classes of xanthine oxidase inhibitors. Baldwin JJ; Kasinger PA; Novello FC; Sprague JM; Duggan DE J Med Chem; 1975 Sep; 18(9):895-900. PubMed ID: 1171986 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: comparison with nepicastat. Bonifácio MJ; Sousa F; Neves M; Palma N; Igreja B; Pires NM; Wright LC; Soares-da-Silva P Eur J Pharmacol; 2015 Mar; 751():50-8. PubMed ID: 25641750 [TBL] [Abstract][Full Text] [Related]
12. Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase. Stanley WC; Li B; Bonhaus DW; Johnson LG; Lee K; Porter S; Walker K; Martinez G; Eglen RM; Whiting RL; Hegde SS Br J Pharmacol; 1997 Aug; 121(8):1803-9. PubMed ID: 9283721 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity. Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368 [TBL] [Abstract][Full Text] [Related]
14. Alternate substrates of dopamine beta-hydroxylase. I. Kinetic investigations of benzyl cyanides as substrates and inhibitors. Colombo G; Rajashekhar B; Giedroc DP; Villafranca JJ J Biol Chem; 1984 Feb; 259(3):1593-600. PubMed ID: 6693426 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure elucidation of 2,3,5,6,7,8-hexahydro-1 H-[1,2,4]triazolo[1,2-a]pyridazine-1-thione, 3,3-disubstituted and 2-substituted derivatives and evaluation of their inhibitory activity against inducible nitric oxide synthase. Schulz U; Freitag M; Schmidt K; Witetschek M; Polzin M; Morgenstern O Pharmazie; 2014 Oct; 69(10):731-44. PubMed ID: 25985562 [TBL] [Abstract][Full Text] [Related]
16. Dopamine-beta-hydroxylase inhibition: a novel sympatho-modulatory approach for the treatment of congestive heart failure. Hegde SS; Friday KF Curr Pharm Des; 1998 Dec; 4(6):469-79. PubMed ID: 10197057 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of 1-substituted-4-ethyl-3-(pyridin-3-yl)-1,2,4-triazoline-5-thione. Wujec M; Pitucha M; Dobosz M Acta Pol Pharm; 2004 Dec; 61 Suppl():13-5. PubMed ID: 15909925 [No Abstract] [Full Text] [Related]
18. [Substituted picolinic acids as DBH inhibitors. Inhibition of dopamine beta-hydroxylase and antihypertensive action]. Piesche L; Hilse H; Oehlke J; Schrötter E; Oehme P Pharmazie; 1983 May; 38(5):335-8. PubMed ID: 6611632 [TBL] [Abstract][Full Text] [Related]
19. [Studies on products of transformation of 4-carboethoxymethyl-1,2,4-triazoline-5-thione derivatives. I. Synthesis of 4-beta-aminoethylo-1,2,4-triazolino-5-thione with potential pharmacological action]. Dobosz M Acta Pol Pharm; 1984; 41(1):43-8. PubMed ID: 6496139 [No Abstract] [Full Text] [Related]
20. Studies of the inhibition of dopamine beta hydroxylase by thiono-sulfur containing compounds. Catignani GL; Neal RA Life Sci; 1975 Jun; 16(12):1915-21. PubMed ID: 1152617 [No Abstract] [Full Text] [Related] [Next] [New Search]